D1 and D2 Dopamine and Opiate Receptors are Involved in the Restraint Stress-Induced Sensitization to the Psychostimulant Effects of Amphetamine

CLAUDIA SOLEDAD DI´AZ–OTAN˜ EZ, NANCY DEL ROSARIO CAPRILES1 AND LILIANA MARINA CANCELA2

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

PERGAMON-ELSEVIER SCIENCE LTD

Año: 1997 vol. 58 p. 9 - 14

0091-3057

DI´AZ–OTAN˜ EZ, C. S., N. CAPRILES AND L. M. CANCELA. D1 and D2 dopamine and opiate receptors are involved in the restraint stress-induced sensitization to the psychostimulant effects of amphetamine.PHARMACOL BIOCHEMBEHAV in the restraint stress-induced sensitization to the psychostimulant effects of amphetamine.PHARMACOL BIOCHEMBEHAV D1 and D2 dopamine and opiate receptors are involved in the restraint stress-induced sensitization to the psychostimulant effects of amphetamine.PHARMACOL BIOCHEMBEHAVPHARMACOL BIOCHEMBEHAV 58(1) 9–14, 1997.—The time course of the restraint stress-induced sensitization to the stimulant effects of amphetamine (AMPH, 0.5 mg/kg IP) on locomotor activity was investigated for up to 8 days. In a series of separate experiments, the involvement of opioid and dopaminergic mechanisms in the development of acute restraint stress-induced behavioral sensitization were characterized. Both a single restraint session (2 h) and chronic restraint (2 h per day for 7 days) similarly potentiated the effects of AMPH on motor activity. This behavioral sensitization was prevented by the administration of naltrexone (2 mg/kg IP), haloperidol (1 mg/kg IP), sulpiride (60 mg/kg IP) or SCH23390 (0.5 mg/kg IP) 10-20 min prior to restraint. These results indicate that 1) the development of sensitization to amphetamine-induced effects on motor activity does not depend on the length of exposure to stress (acute or chronic), 2) the stimulation of both D1 and D2 dopaminergic receptors is necessary for the development of the restraint stress-induced sensitization to AMPH and 3) an opioid system is also implicated in this sensitization process. Ó 1997 Elsevier Science Inc. receptors is necessary for the development of the restraint stress-induced sensitization to AMPH and 3) an opioid system is also implicated in this sensitization process. Ó 1997 Elsevier Science Inc. (AMPH, 0.5 mg/kg IP) on locomotor activity was investigated for up to 8 days. In a series of separate experiments, the involvement of opioid and dopaminergic mechanisms in the development of acute restraint stress-induced behavioral sensitization were characterized. Both a single restraint session (2 h) and chronic restraint (2 h per day for 7 days) similarly potentiated the effects of AMPH on motor activity. This behavioral sensitization was prevented by the administration of naltrexone (2 mg/kg IP), haloperidol (1 mg/kg IP), sulpiride (60 mg/kg IP) or SCH23390 (0.5 mg/kg IP) 10-20 min prior to restraint. These results indicate that 1) the development of sensitization to amphetamine-induced effects on motor activity does not depend on the length of exposure to stress (acute or chronic), 2) the stimulation of both D1 and D2 dopaminergic receptors is necessary for the development of the restraint stress-induced sensitization to AMPH and 3) an opioid system is also implicated in this sensitization process. Ó 1997 Elsevier Science Inc. receptors is necessary for the development of the restraint stress-induced sensitization to AMPH and 3) an opioid system is also implicated in this sensitization process. Ó 1997 Elsevier Science Inc. (1) 9–14, 1997.—The time course of the restraint stress-induced sensitization to the stimulant effects of amphetamine (AMPH, 0.5 mg/kg IP) on locomotor activity was investigated for up to 8 days. In a series of separate experiments, the involvement of opioid and dopaminergic mechanisms in the development of acute restraint stress-induced behavioral sensitization were characterized. Both a single restraint session (2 h) and chronic restraint (2 h per day for 7 days) similarly potentiated the effects of AMPH on motor activity. This behavioral sensitization was prevented by the administration of naltrexone (2 mg/kg IP), haloperidol (1 mg/kg IP), sulpiride (60 mg/kg IP) or SCH23390 (0.5 mg/kg IP) 10-20 min prior to restraint. These results indicate that 1) the development of sensitization to amphetamine-induced effects on motor activity does not depend on the length of exposure to stress (acute or chronic), 2) the stimulation of both D1 and D2 dopaminergic receptors is necessary for the development of the restraint stress-induced sensitization to AMPH and 3) an opioid system is also implicated in this sensitization process. Ó 1997 Elsevier Science Inc. receptors is necessary for the development of the restraint stress-induced sensitization to AMPH and 3) an opioid system is also implicated in this sensitization process. Ó 1997 Elsevier Science Inc. 1 and D2 dopaminergic receptors is necessary for the development of the restraint stress-induced sensitization to AMPH and 3) an opioid system is also implicated in this sensitization process. Ó 1997 Elsevier Science Inc.Ó 1997 Elsevier Science Inc.